Canopy Growth (CGC) Cash & Current Investments (2017 - 2026)

Canopy Growth (CGC) reported Cash & Current Investments of $265.9 million for Q1 2026, up 190.25% on a YoY basis from $91.6 million in Q1 2025, and little changed sequentially from $266.3 million in Q4 2025.

Canopy Growth (CGC) Cash & Current Investments (2017 - 2026) Analysis & Trends

Canopy Growth (CGC) has 10 years of Cash & Current Investments data on file, last reported at $265.9 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 190.25% year-over-year to $265.9 million; the trailing twelve-month figure through Mar 2026 stood at $265.9 million (up 190.25% YoY), and the FY2026 full-year result was $265.9 million, up 190.25% from the prior year.
  • Cash & Current Investments steadied at $265.9 million in Q1 2026, from $266.3 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $1.1 billion in Q1 2022 to a low of $91.6 million in Q1 2025.
  • A 5-year average of $354.6 million and a median of $187.2 million in 2023 frame the typical range for Cash & Current Investments.
  • Across the five-year window, Cash & Current Investments plunged 78.65% in 2023 and jumped 190.25% in 2026, its largest moves.
  • Tracing CGC's Cash & Current Investments over 5 years: stood at $581.4 million in 2022, then plunged by 76.48% to $136.8 million in 2023, then decreased by 6.65% to $127.7 million in 2024, then jumped by 108.57% to $266.3 million in 2025, then dropped by 0.13% to $265.9 million in 2026.
  • Business Quant data shows CGC's Cash & Current Investments at $265.9 million in Q1 2026, $266.3 million in Q4 2025, and $94.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 3.74 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 428.00 Mn
10 Canopy Growth 276.52 Mn 10.60 Mn - 265.93 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 265.93 Mn
Dec 31, 2025 266.27 Mn
Sep 30, 2025 94.07 Mn
Jun 30, 2025 95.29 Mn
Mar 31, 2025 91.62 Mn
Dec 31, 2024 127.67 Mn
Sep 30, 2024 172.93 Mn
Jun 30, 2024 146.12 Mn
Mar 31, 2024 131.81 Mn
Dec 31, 2023 136.76 Mn
Sep 30, 2023 187.20 Mn
Jun 30, 2023 403.79 Mn
Mar 31, 2023 413.25 Mn
Dec 31, 2022 581.44 Mn
Sep 30, 2022 876.71 Mn
Jun 30, 2022 954.63 Mn
Mar 31, 2022 1.08 Bn
Dec 31, 2021 1.13 Bn
Sep 30, 2021 651.29 Mn
Jun 30, 2021 467.11 Mn